Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2016 | Why European Reference Networks are a game-changer for collaboration in hematology

Jan Geissler • 12 Jun 2016
EHA 2016
General

The Patient Advocacy Session at EHA 2016 focused on the European Reference Networks (ERN). Initiated by the European Commission and supported by all Member States, ERNs aim to address common challenges faced by professionals when diagnosing and providing highly specialized healthcare in complex rare diseases in fields such as hematology. The emerging hematology ERN, EuroBloodNet, will improve clinical outcomes and quality of life of people living with blood diseases. Patient advocate Jan Geissler explains how clinicians, the EHA and patient organizations are joining forces to establish EuroBloodNet.

More from Jan Geissler

The need for patient advocates to attend major congresses such as EBMT
1:21
The need for patient advocates to attend major congresses such as EBMT
Jan Geissler • 24 Mar 2019
The evolution of patient advocacy
1:14
The evolution of patient advocacy
Jan Geissler • 24 Mar 2019
The importance of patient advocacy tracks at congresses
1:28
The importance of patient advocacy tracks at congresses
Jan Geissler • 24 Mar 2019
The aims of the Patvocates Network
0:53
The aims of the Patvocates Network
Jan Geissler • 24 Mar 2019

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals